The magnetic resonance imaging market has conventionally
risen on the back of an advanced imaging technique, which has boosted adoption
of the high-cost hardware, and software imaging. In turn, the advancement in
the MRI imaging market continues to pave way for unimaginable possibilities in
detection of several anomalies in critical organs like brain. Moreover, the
prospect of the market remained limited earlier as CT imaging continued to be
more cost-effective, and effective for applications like lung imaging. However,
new products like Toshiba’s new Ultrashort Echo Time (UTE) enables clinicians
to view high susceptibility regions, where conventionally the MR imaging signal
used to disappear. Advanced products like this, and GE Healthcare’s MAGiC,
promise lower turnaround times for MRI imaging, which is critical in care for
chronic diseases, and rising elderly population.
The advancements in MRI imaging aren’t limited to a few
players either. Some other key players in the magnetic resonance imaging market
are Koninklijke Philips N.V., AllTech Medical Systems, Esaote SpA, Hitachi,
Ltd., Siemens Healthcare GmbH. The main players in the market are
investing in more research and development as the Unique Selling Point of MRI
imaging continues to remain its technological superiority over conventional
techniques. The FDA also approved two Siemens MRI applications, one of which
makes way for simultaneous imaging, while the other reduces 2D imaging
acquisition times by a multiple of 8 as per the official company sources.
Brain Imaging Continues
to Remain Important
It is estimated that brain imaging accounts for 1 out of
every 4 scans that take place. Additionally, the conventional delays in MRI
imaging are expected to go away in the near future, thanks to new product
launches. Technologies like GOBrain, promise to significantly reduce time taken
for scans. Additionally, rising fatalities due to accidents, and chronic
diseases like Alzheimer’s, and HIV are expected to result in over 45 million
potential cases for brain scans worldwide. Moreover, the advancements in
technologies promise to shorter the imaging process in line with clinical
routine. The shorter scans and imaging times are essential for elderly
patients, who can exhibit lower tolerance to treatments, and require urgent
care on a consistent basis.
Neurological Illnesses to
Promise a New Arena for Growth in the MRI Market
According to a recently published in Public Health
journal, the deaths from neurological diseases is on the rise in developed
countries. The rise is notable with a 10% increase in fatalities among men for
neurological disease in seven countries. These countries include UK, Australia,
Canada, Spain, Germany, Italy, US, and the UK. A wide variety of neurological
illnesses mainly Epilepsy, Dementia, Multiple Sclerosis, Headache disorders,
and Neuroinfections require advanced brain imaging techniques like MRI for
effective treatment. The recent advancements in diagnostics, and growing surge
of neurological disorders like Alzheimer’s, and reimbursement mechanisms for
growth will promise new opportunities for players in the magnetic resonance
imaging market.
More Trending Reports by
Transparency Market Research:
About Us
Transparency Market Research (TMR) is a market
intelligence company, providing global business information reports and
services. Our exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers. We have an
experienced team of Analysts, Researchers, and Consultants, who use
proprietary data sources and various tools and techniques to gather, and
analyze information. Our business offerings represent the latest and the
most reliable information indispensable for businesses to sustain a
competitive edge.
Each TMR Syndicated Research report covers a different
sector — such as pharmaceuticals, chemical, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These reports
provide in-depth analysis and deep segmentation to possible micro levels. With
wider scope and stratified research methodology, our syndicated reports thrive
to provide clients to serve their overall research requirement.
Contact
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
